Delivery Order SPE2DB20D1100-SPE2DB24FC7W3
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of fexofenadine HCL 180 mg tablets. The fixed-price delivery order, valued at $6,727.46, has a completion date of January 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Fexofenadine HCL 180 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type, valued at $1,422.24, and has a period of performance through February 21, 2024. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.01, is a Delivery Order for 4,566,970,272 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,180.81 firm-fixed-price delivery order is for the supply of 4,565,962,852 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,061 firm-fixed-price delivery order is for the supply of 4,566,211,485 units of Fexofenadine HCL 180 mg tablets in 500-count containers, with a period of performance through October 28, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the delivery of 4,565,518,871 units of Fexofenadine HCL 180 mg tablets to the Defense Logistics Agency (DLA). The $3,351.60 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,184.35 Firm Fixed Price Delivery Order contract is for the supply of 4,567,019,980 tablets of Fexofenadine HCL 180 mg, with a completion date of January 24, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,930.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,615,751 units of Fexofenadine HCL 180 mg tablets in 500-count bottles. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Fexofenadine HCL 180 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $3,051.83, has an ultimate completion date of March 28, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCL 180 mg tablets. The $1,813.85 firm-fixed-price contract has a completion date of September 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical...